Author:
Setyowatie Lita,SHW Tantari,Yulian Inneke
Abstract
Background: Gonorrhea remains the second most common sexually transmitted infection (STI) in the world with an increasing number of cases. Oral cefixime and IM ceftriaxone are still the mainstay therapy for gonorrhea in Indonesia. However, previous studies suggested possible resistance to ceftriaxone and cefixime, which are the first-line treatment of gonorrhea. To date, there are no data available regarding the susceptibility of these antibiotics for the treatment of gonorrhea in Dr. Saiful Anwar General Hospital (RSSA) Malang. Purpose: Determine susceptibility pattern of Neisseria gonorrhoeaetowards cefixime and ceftriaxone in RSSA Malang. Methods: The samples were patients of the Outpatient Clinic of Dermatology and Venereology Department with a symptom of discharge which contained Gram-negative diplococcus after Gram staining and had a positive culture of Neisseria gonorrhoeae. Susceptibility testing for cefixime and ceftriaxone antibiotics were performed using the Kirby-Bauer method. The data are presented in percentages. Result: Antibiotic susceptibility test results showed that 80.77% of Neisseria gonorrhoeaeisolates were still susceptible to cefixime, and 80.77% of isolates were still susceptible to ceftriaxone. Conclusion: Cefixime and ceftriaxone are still effective as gonorrhea therapy in RSSA Malang.
Reference25 articles.
1. Meeting the Public Health Challenge of Multidrug and Extensively Drug-Resistant Neisseria gonorrhoeae;J.W;Expert Rev Anti Infect Ther,2009
2. Unemo M, Nicholas RA. Emergence of Multidrug-Resistant Extensively Drug-Resistant and Untreatable Gonorrhea, Future Microbiol 2012; 7(12):1401-22.
3. World Health Organization. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections. Geneva: WHO Press; 2012.
4. Center for Diseases Control and Prevention (CDC). Sexually Transmitted Disease Surveillance 2016, Division of STD Prevention. Atlanta: CDC; 2017.
5. World Health Organization. Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. Geneva: WHO Press; 2008.